Cardinal Health Profit Margin 2010-2023 | CAH

Current and historical gross margin, operating margin and net profit margin for Cardinal Health (CAH) over the last 10 years. Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. Cardinal Health net profit margin as of September 30, 2023 is 0.07%.
Cardinal Health Annual Profit Margins
Cardinal Health Quarterly Profit Margins
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $26.392B $205.012B
Cardinal Health Inc. is a nation-wide drug distributor and provider of services to pharmacies, healthcare providers and manufacturers. The company has two reporting segments: Pharmaceutical and Medical. The Pharmaceutical segment is the second largest pharmaceutical distributor in the United States and the largest nuclear pharmacy. Its products and services include pharmaceutical distribution, manufacturer and specialty services, and nuclear and pharmacy services. The Medical segment manufactures products such as single-use surgical drapes, gowns and apparel; exam and surgical gloves; and fluid suction and collection systems and offers sterile and non-sterile procedure kits. These products are sold directly or distributed via third-party sources in the U.S., Canada, Europe, South America and the Asia/Pacific.?
Stock Name Country Market Cap PE Ratio
Becton Dickinson (BDX) United States $68.588B 19.33
McKesson (MCK) United States $62.614B 17.06
West Pharmaceutical Services (WST) United States $25.953B 43.74
Labcorp (LH) United States $18.416B 14.70
Cooper (COO) United States $16.686B 27.89
Align Technology (ALGN) United States $16.375B 35.87
Henry Schein (HSIC) United States $8.714B 13.21
DENTSPLY SIRONA (XRAY) United States $6.727B 17.16
Merit Medical Systems (MMSI) United States $4.133B 23.93
CONMED (CNMD) United States $3.299B 38.17
Patterson (PDCO) United States $2.355B 10.77
STAAR Surgical (STAA) United States $1.531B 69.69
Atrion (ATRI) United States $0.543B 25.53
Lifevantage (LFVN) United States $0.080B 20.35
Pro-Dex (PDEX) United States $0.057B 19.01
Biolase (BIOL) United States $0.003B 0.00